Paper II
2022 May (Supplementary) (2010 Scheme)

Question

Bisphosphonates used in postmenopausal Osteoporosis.

Q190.3 marksShort Answers

Answer

Alendronate, Risedronate (also Zoledronic acid) — bind hydroxyapatite in bone and inhibit osteoclast-mediated bone resorption, increasing bone mineral density; first-line for postmenopausal osteoporosis, taken on an empty stomach with the patient upright for 30 minutes to reduce esophageal irritation.

Other Years Asked


Revise MBBS
Preview